Go Deep
ImageneBio, Inc.
ImageneBio, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 22,187 | -1.0 | 0.33 | 0.01 | 394.08 |
| Oct 2026 | 22,258 | -1.0 | 0.32 | 0.01 | 382.69 |
| Oct 2026 | 22,252 | -1.0 | 0.32 | 0.01 | 382.65 |
| Oct 2026 | 22,275 | -1.0 | 0.32 | 0.01 | 379.27 |
| Oct 2026 | 22,199 | -1.0 | 0.33 | 0.01 | 391.59 |
| Oct 2026 | 22,225 | -1.0 | 0.33 | 0.01 | 386.37 |
| Oct 2026 | 22,249 | -1.0 | 0.32 | 0.01 | 381.81 |
ImageneBio, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -10,178,000.0 | -10,619,000.0 | -6,908,000.0 | -24,779,000.0 |
| EPS | -0.6 | -0.9 | — | -2.9 |
ImageneBio, Inc. Revenue & Profit: Last 3 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 |
|---|---|---|---|
| Revenue | 800,000.0 | 3,500,000.0 | 7,962,000.0 |
| Net Profit | -45,349,000.0 | -36,568,000.0 | -21,148,000.0 |
| EPS | -9.6 | -4.3 | -2.9 |
ImageneBio, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 |
|---|---|---|---|
| Total Assets | 152,976,000.0 | 15,922,000.0 | 31,245,000.0 |
| Total Liabilities | 19,837,000.0 | 176,487,000.0 | 157,353,000.0 |
| Total Equity | 133,139,000.0 | -160,565,000.0 | -126,108,000.0 |
Owes vs Owns
ImageneBio, Inc. owed $0.07 for every $1 it owned in Jun 2026, down from $5.04 in Dec 2023.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.07× | 0.13× | 11.1× | 5.04× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
ImageneBio, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 88.5%Receivables 0.8%Fixed assets (tangible) 0.5%Other assets 10.2%
How it's funded — Dec 2025
Short-term debt 1.5%Payables 0.9%Other liabilities 10.1%Shareholders' equity 87.0%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 |
|---|---|---|---|
| Assets | |||
| Cash & short-term investments | 135.3 | 12.1 | 25.5 |
| Receivables | 1.3 | 0.1 | 0.2 |
| Inventory | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.8 | 0.6 | 4.3 |
| Intangible assets | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.9 | 0.9 |
| Other assets | 15.5 | 2.2 | 0.3 |
| Liabilities & equity | |||
| Short-term debt | 2.3 | 7.5 | 0.4 |
| Long-term debt | 0.7 | 0.2 | 0.6 |
| Payables | 1.4 | 5.3 | 5.9 |
| Other liabilities | 15.4 | 163.5 | 150.5 |
| Shareholders' equity | 133.1 | -160.6 | -126.1 |
| Net tangible assets | 133.1 | -160.6 | -126.1 |
ImageneBio, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 |
|---|---|---|---|
| Operating Activities | -47,844,000.0 | -21,319,000.0 | -18,233,000.0 |
| Investing Activities | -5,814,000.0 | 11,123,000.0 | -10,454,000.0 |
| Financing Activities | 135,468,000.0 | 6,906,000.0 | 150,000.0 |